BD-112

N/A

Report date: 2025/08/14 17:46:56

Base Information

Drug NameBD-112
Drug Alias NameBD112BD-112
ClassificationCell and gene therapy > Gene therapy > Gene editing > CRISPR
Mechanisms of ActionGene transferenceHuntingtin modulators
TargetsHuntingtin
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai BDgene Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai BDgene Co Ltd
Inactive CompaniesN/A
Active IndicationsHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A